Standby Equity Distribution Agreement

Corporate Update

Retrieved on: 
Saturday, November 25, 2023

The ATM Program is intended to replace the Company's at-the-market equity program that commenced in December 2022 and expires on November 27, 2023.

Key Points: 
  • The ATM Program is intended to replace the Company's at-the-market equity program that commenced in December 2022 and expires on November 27, 2023.
  • The Company is not obligated to make any sales of Offered Shares under the Distribution Agreement.
  • Any Offered Shares sold under the ATM Program will be sold at the prevailing market price at the time of sale.
  • In addition, the Lead Agent will send copies of such documents to investors upon request.

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

Retrieved on: 
Tuesday, September 26, 2023

VANCOUVER, BC, Sept. 25, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), is pleased to announce that it has established an at-the-market equity offering program (the "ATM Program") that allows the Company to issue and sell up to C$10,000,000 of common shares in the capital of the Company (the "Common Shares") from time to time, at the Company's discretion and subject to regulatory requirements.

Key Points: 
  • VANCOUVER, BC, Sept. 25, 2023 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), is pleased to announce that it has established an at-the-market equity offering program (the "ATM Program") that allows the Company to issue and sell up to C$10,000,000 of common shares in the capital of the Company (the "Common Shares") from time to time, at the Company's discretion and subject to regulatory requirements.
  • All Common Shares issued under the ATM Program will be sold in transactions that are deemed to be "at-the-market" distributions as defined in National Instrument 44-102 – Shelf Distributions.
  • The ATM Program provides the Company with enhanced flexibility should future additional financing be required, and it may be activated if and as deemed appropriate.
  • Distributions of the Common Shares under the ATM Program, if any, will be made pursuant to the terms of the Distribution Agreement.

Fortis Inc. Establishes At-The-Market Equity Program

Retrieved on: 
Tuesday, September 19, 2023

The ATM Program provides Fortis with additional financing flexibility to fund its capital program.

Key Points: 
  • The ATM Program provides Fortis with additional financing flexibility to fund its capital program.
  • The volume and timing of distributions under the ATM Program, if any, will be determined at the Corporation's sole discretion.
  • The ATM Program will be effective until December 22, 2024 unless terminated prior to such date by the Corporation.
  • Fortis intends to use the net proceeds from the ATM Program, if any, for general corporate purposes.

Electra Provides Notice of Change of Auditors

Retrieved on: 
Tuesday, September 19, 2023

Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Corporation”) announced today that it has changed its auditors from KPMG LLP (“Former Auditor”) to MNP LLP, Chartered Professional Accountants (“Successor Auditor”) effective September 18, 2023.

Key Points: 
  • Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Corporation”) announced today that it has changed its auditors from KPMG LLP (“Former Auditor”) to MNP LLP, Chartered Professional Accountants (“Successor Auditor”) effective September 18, 2023.
  • At the request of the Corporation, the Former Auditor resigned as the auditor of Electra effective September 14, 2023.
  • Electra’s Board of Directors appointed the Successor Auditor as the Corporation’s auditor effective September 18, 2023 until the next Annual General Meeting of the Corporation.
  • In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the board of directors of the Corporation and filed on SEDAR.

Artroniq Enters Transformative Distribution Agreement with PT. Terang Dunia Internusa

Retrieved on: 
Monday, September 11, 2023

("AiTech" or "Distributor"), has entered into a transformative Distribution Agreement with PT.

Key Points: 
  • ("AiTech" or "Distributor"), has entered into a transformative Distribution Agreement with PT.
  • Terang Dunia Internusa, the parent company of Indonesia's renowned United Motors.
  • Terang Dunia Internusa, has been an industrial stalwart in Indonesia since its inception in 1971.
  • Terang Dunia Internusa (United Motors) added, "Artroniq's unwavering dedication to innovation and sustainability seamlessly complements our strategic vision at PT.

Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

Retrieved on: 
Thursday, September 7, 2023

TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that it has closed its previously announced ”bought deal” private placement of 9.0% convertible unsecured senior notes due November 1, 2026 (the “Notes") of the Company at a price of US$1,000 per Note (the “Issue Price”) for aggregate gross proceeds of US$4,553,000 (the "Offering"). The Offering was conducted by Paradigm Capital Inc. (the “Underwriter”) and consisted of the sale of 4,553 Notes at a price of US$1,000 per Note.

Key Points: 
  • The Offering was conducted by Paradigm Capital Inc. (the “Underwriter”) and consisted of the sale of 4,553 Notes at a price of US$1,000 per Note.
  • The Notes have a face value of US$1,000 per Note, bear interest of 9% and are due on November 1, 2026 (the “Maturity Date”).
  • Each Note is convertible into approximately 15,475,647 Common Shares, subject to customary anti-dilution and make whole fundamental change adjustments.
  • Chris Seto, Chief Executive Officer of Spectral Medical, stated, “We remain encouraged by the continued momentum and pace of patient enrollment in the Tigris study.

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

Retrieved on: 
Thursday, September 7, 2023

The volume and timing of distributions under the ATM Program will be determined at the Company’s discretion.

Key Points: 
  • The volume and timing of distributions under the ATM Program will be determined at the Company’s discretion.
  • 333-263248) (the “Registration Statement”), filed with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended.
  • The timing and extent of the use of the ATM Program will be at the discretion of the Company.
  • Copies of the Distribution Agreement, the Prospectus Supplement and the Base Shelf Prospectus are available on SEDAR+ at www.sedarplus.ca and the Distribution Agreement, the U.S.

POET Technologies Refreshes "At-the-Market" Public Offering in the United States

Retrieved on: 
Friday, September 1, 2023

Sales of the Company’s common shares, if any, through the Agent will be made through "at-the-market" issuances, including, without limitation, sales made directly on the Nasdaq Stock Market in the United States.

Key Points: 
  • Sales of the Company’s common shares, if any, through the Agent will be made through "at-the-market" issuances, including, without limitation, sales made directly on the Nasdaq Stock Market in the United States.
  • The ATM Program continues the Company's relationship with Craig-Hallum as Agent and succeeds the Company's prior "at-the-market" equity sales program established on June 29, 2023 in Canada and the United States.
  • Since the common shares will be distributed at market prices prevailing at the time of the sale, prices may vary between purchasers and during the period of distribution.
  • The Prospectus will be available on SEDAR at www.sedar.com , and the Registration Statement and the Prospectus can be found on EDGAR at www.sec.gov .

Cybin Announces Renewed At-The-Market Equity Program of up to US$35 Million

Retrieved on: 
Thursday, August 24, 2023

Cybin intends to use the net proceeds from sales of Shares under the ATM Program, if any, for growth opportunities and working capital initiatives.

Key Points: 
  • Cybin intends to use the net proceeds from sales of Shares under the ATM Program, if any, for growth opportunities and working capital initiatives.
  • The ATM Program will be effective until the earlier of the issuance and sale of all of the Shares issuable pursuant to the ATM Program and September 17, 2025 unless earlier terminated in accordance with the terms of the Distribution Agreement.
  • The volume and timing of distributions under the ATM Program, if any, will be determined in Cybin’s sole discretion and in accordance with the Distribution Agreement.
  • The Supplement and accompanying Base Prospectus contain important detailed information about the ATM Program.

Abaxx Provides Corporate Update and Quarterly Development Activities

Retrieved on: 
Wednesday, August 16, 2023

TORONTO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (NEO:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of the Abaxx Commodity Exchange and Clearinghouse (“Abaxx Singapore”), and producer of the SmarterMarkets™ Podcast, summarizes development activities over the past quarter and the general progress of the Company’s business plans.

Key Points: 
  • Exchange Product Development: Abaxx Singapore is finalizing Stage 3 of its nickel-related product development — focused on industry, risk, and regulatory considerations.
  • Abaxx Group Development Company Base Carbon Delivers First Revenues to Abaxx Technologies: In Q2-2023, Abaxx achieved an important corporate milestone by recognizing first revenues on the Company’s 2.5% gross revenue royalty on Base Carbon sales, the first group revenue from an organic development project within Abaxx.
  • The Company plans to host a quarterly business update investor presentation, to provide a business update and respond to investor questions.
  • The Company invites current and prospective shareholders to attend this quarterly business update and Q&A session with the Abaxx executive team.